ArticleMolecular medicine reports2017

Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.

Sheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.